Skip to main content
Patient Recruitment

Science 37 delivers medical record qualified participants to enrolling sites.

The Recruitment Roadblock:
How Low-Quality Referrals Delay Your Trial’s Success

The problem with traditional recruitment

The problem with traditional recruitment

Traditional clinical trial recruitment models face a major challenge—low-quality patient referrals. On average, only 5% of referrals are fully qualified, leaving research sites overwhelmed with unqualified leads. Many referrals fail to meet basic inclusion/exclusion criteria or are not medically suitable, resulting in wasted time and effort.

 

The impact of low-quality referrals

The influx of unqualified referrals creates several issues:

Site Fatigue: Research sites become overwhelmed, diverting attention from the few qualified participants. Slower

Recruitment: Processing large numbers of unqualified leads slows down the recruitment process.

 

Key delays caused by poor referrals

80% of studies are postponed due to recruitment issues

50% of sites enroll only one or no participants, hindering trial progress

40% of sites under-enroll study participants, leading to costly delays

The problem with traditional recruitment

Traditional clinical trial recruitment models face a major challenge—low-quality patient referrals. On average, only 5% of referrals are fully qualified, leaving research sites overwhelmed with unqualified leads. Many referrals fail to meet basic inclusion/exclusion criteria or are not medically suitable, resulting in wasted time and effort.

 

The impact of low-quality referrals

The influx of unqualified referrals creates several issues:

Site Fatigue: Research sites become overwhelmed, diverting attention from the few qualified participants. Slower

Recruitment: Processing large numbers of unqualified leads slows down the recruitment process.

 

Key delays caused by poor referrals

80% of studies are postponed due to recruitment issues

50% of sites enroll only one or no participants, hindering trial progress

40% of sites under-enroll study participants, leading to costly delays

The problem with traditional recruitment

Science 37's Solution:
100% Medical Record Qualified Referrals

Eligible patients. Quality referrals.

Eligible patients. Quality referrals.

Science 37’s patent-protected patient recruitment solution ensures that 100% of our patient referrals are medical record qualified. This means that every participant has been rigorously screened to meet study criteria, eliminating the issue of unqualified leads.

Eligible patients. Quality referrals.

Science 37’s patent-protected patient recruitment solution ensures that 100% of our patient referrals are medical record qualified. This means that every participant has been rigorously screened to meet study criteria, eliminating the issue of unqualified leads.

Eligible patients. Quality referrals.
Clinician-reviewed screening.

Clinician-reviewed screening.

Our dedicated team of internal doctors and nurses thoroughly qualifies each participant, allowing research sites to focus on ready-to-go patients rather than sifting through loosely qualified referrals.

Clinician-reviewed screening.

Clinician-reviewed screening.

Our dedicated team of internal doctors and nurses thoroughly qualifies each participant, allowing research sites to focus on ready-to-go patients rather than sifting through loosely qualified referrals.

Enhanced efficiency and enrollment.

Enhanced efficiency and enrollment.

By providing only high-quality referrals, Science 37 improves recruitment efficiency and increases enrollment rates. Whether your trial requires large-scale recruitment or access to hard-to-find patient populations, our approach benefits both sponsors and sites, speeding up the path to success.

Enhanced efficiency and enrollment.

By providing only high-quality referrals, Science 37 improves recruitment efficiency and increases enrollment rates. Whether your trial requires large-scale recruitment or access to hard-to-find patient populations, our approach benefits both sponsors and sites, speeding up the path to success.

Enhanced efficiency and enrollment.

Over 10 Years of Results

Science 37 leverages comprehensive patient datasets and predictive modeling, drawing on our experience as a clinical research site to produce actionable targeting insights. These insights guide our structured, repeatable processes to ensure transparent and efficient recruitment, optimizing patient selection and ensuring accuracy throughout the process.

Our vast network of patient communities and referral partnerships enables us to reach diverse participant pools. This expansive reach ensures we meet even the most challenging recruitment and enrollment targets.

Dedicated patient engagement team Our patient engagement team provides continuous support throughout the study, working closely with participants and sites to enhance retention, satisfaction, and overall trial success.

Delivering Results for Sponsors and Sites

Reduced site burnout.

By delivering medical record qualified participants directly to sites, Science 37 helps sponsors eliminate common issues such as disengaged site staff and referral diversion to competing studies. This streamlined approach fosters a more engaged and productive site environment.

Performance-based pricing.

Our ability to find high-quality patients allows us to offer over 90% performance-based pricing, significantly minimizing financial risk for sponsors. This model aligns our success with yours, ensuring a partnership focused on results.

Personalized recruitment strategies.

We tailor recruitment strategies to meet the specific needs of each study, utilizing data-driven insights and innovative methods to maximize outcomes. Every strategy is meticulously documented and shared with sponsors, providing full transparency and a clear view of progress.

Unlock The Full Potential of Your Trial

Connect with our team to explore how we can support your next study.

Unlock The Full Potential of Your Trial

Connect with our team to explore how we can support your next study.